← Eichor
Study identifier: NCT05990881 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

Condition: Carpometacarpal Sprain · Thumb Sprain · Clostridium; Botulinum  ·  Sponsor: Rhode Island Hospital

PhasePhase 3
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no alternative to this injection medicine. This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid injection. The difference between Botox and steroid injections is that they are different medicines and work in different ways. Botox, as it is being used in this study, is not FDA-approved. It is therefore considered an investigational medicine.

This description comes directly from the study's public registry record.

Talk to the study team

Reena A Bhatt, MD  ·  (401) 444-2701  ·  RBhatt@brownhealth.org

Vinay Rao, MD  ·  8133856534  ·  vinayrao33@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

235 Plain StreetProvidence, Rhode Island, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05990881